Royalty Pharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019	2018
Market Capitalization	12,659	16,782	23,997	24,196	30,386	-	-
Market Cap Growth	-	-30.07%	-0.82%	-20.37%	-	-	-
Enterprise Value	17,561	21,683	28,686	28,489	33,553	5,445	4,133
PE Ratio	11.09	14.79	560.27	39.04	31.16	-	-
PS Ratio	5.38	7.13	10.73	10.57	14.32	-	-
PB Ratio	1.26	1.66	2.52	2.36	3.07	-	-
P/FCF Ratio	4.25	5.64	11.19	12.10	14.93	-	-
P/OCF Ratio	4.24	5.62	11.19	11.99	14.93	-	-
EV/Sales Ratio	7.46	9.21	12.82	12.44	15.81	3.00	2.30
EV/EBITDA Ratio	13.28	16.40	124.29	36.25	29.64	2.08	2.49
EV/EBIT Ratio	13.28	16.40	124.29	36.25	29.64	2.08	2.49
EV/FCF Ratio	5.90	7.29	13.38	14.25	16.49	3.84	2.55
Debt / Equity Ratio	0.61	0.61	0.75	0.69	0.59	1.02	1.45
Debt / EBITDA Ratio	4.64	4.64	30.83	9.03	5.14	2.38	3.93
Debt / FCF Ratio	2.06	2.06	3.32	3.55	2.86	4.40	4.03
Quick Ratio	7.87	7.87	2.11	16.77	8.73	2.50	4.45
Current Ratio	7.90	7.90	2.19	16.81	8.76	2.50	4.50
Asset Turnover	0.14	0.14	0.13	0.14	0.14	0.15	-
Interest Coverage	7.06	7.06	1.23	4.73	7.21	9.74	5.92
Return on Equity (ROE)	11.50%	11.50%	0.40%	6.10%	16.50%	44.30%	-
Return on Assets (ROA)	6.80%	6.80%	0.20%	3.70%	6.40%	19.70%	-
Return on Capital (ROIC)	9.20%	9.20%	1.85%	8.25%	10.15%	21.25%	12.40%
Earnings Yield	8.96%	6.76%	0.18%	2.56%	3.21%	-	-
FCF Yield	23.50%	17.73%	8.93%	8.26%	6.70%	-	-
Dividend Yield	2.99%	2.80%	1.90%	1.70%	0.60%	-	-
Payout Ratio	33.20%	31.50%	760.00%	45.60%	22.70%	-	-
Buyback Yield / Dilution	-37.66%	-37.66%	-5.59%	-10.48%	36.94%	-	-
Total Shareholder Return	-34.66%	-34.86%	-3.69%	-8.78%	37.54%	-	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).